U.S. C-Arms Market Value to Reach USD 2.06 billion by 2030; Integration of AI in C-Arms to Augment Market Growth

The U.S. c-arms market size touched USD 0.95 billion in 2022 and is predicted to reach USD 1.04 billion in 2023. The market is anticipated to touch USD 2.06 billion by 2030, recording a CAGR of 10.3% over 2023-2030.

Fortune Business Insights™ presents this information in its latest report titled “U.S. C-arms Market Size, Share & COVID-19 Impact Analysis, By Type (Fixed C-arms, Mobile C-arms {Full-Size C-arms, Mini C-arms}), By Application (Orthopedics & Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detector and Image Intensifier), By End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) and Forecast, 2023-2030”.

C-arms refer to cutting-edge medical scanners that use X-ray technology to analyze various parts of a patient’s body. They are majorly used for fluoroscopic imaging while carrying out various orthopedic and surgical procedures. They are also utilized in gastroenterological and urological surgeries. The increasing preference for minimally invasive surgeries among patients due to their many advantages is predicted to fuel the U.S. c-arms market growth.

Notable Decrease in Surgeries Slowed Market Growth During COVID-19 Pandemic

The COVID-19 pandemic caused a major decline in the sales of c-arm machines as the U.S. government had asked hospitals and ambulatory surgical centers to prioritize the treatment of COVID-19 positive patients. This meant that most of the elective or non-essential surgical appointments were either postponed or canceled. This scenario had a negative impact on the revenue margins of several leading companies operating in this market due to factors, such as supply chain disruptions and postponement of installation of c-arms. These factors impeded market progress during the COVID-19 outbreak.

Omega Medical Imaging Installed First AI Image-Guided Interventional Systems in Hospitals Across Hawaii

Omega Medical Imaging LLC announced that it had installed the first AI image-guided interventional system, named the E-View.AI, in healthcare facilities and hospitals across Hawaii. The new interventional endoscopy system claims to offer cutting-edge AI-powered technology that can drastically reduce patients’ and staffs’ exposure to radiation while carrying out endoscopic procedures.

Integration of AI in C-Arm Machines to Augment Market Growth

Some of the major companies operating in this market are focusing on intensifying their research and development activities to improve the performance of c-arm machines. They are also introducing various advanced technologies, such as Artificial Intelligence (AI) to boost the efficiency of their products. Incorporating 3D imaging features into machines can provide a wide range of benefits, such as enhanced real-time intraoperative guidance, improvement in planning surgical procedures, and decreased procedure time, among many others. These developments are projected to bolster the market progress in the coming years.

However, increasing use of refurbished devices may stifle market growth.

Increasing Launch of Novel Products to Help Key Companies Boost Their Market Dominance

The competitive landscape of the U.S. market is quite consolidated as few key companies have captured a sizeable share of the market. GE Healthcare, Siemens Healthcare GmbH, and Koninklijke Philips N.V. are some of the key players dominating the U.S. c-arms market share. These firms are increasing their focus on launching technologically advanced products to fulfill the strong demand for innovative medical devices among healthcare providers. This move will also help them boost their dominance in the market. Some of the other market players include Shimadzu Corporation, CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Corporation, Hologic Inc., Ziehm Imaging GmbH, and many others.

Notable Industry Development:

• November 2021 – Fujifilm Holdings Corporation introduced the Persona CS mobile C-arm to expand its product range and offer high-quality image guidance in different surgical procedures, such as orthopedic & trauma surgeries, pain management, and others.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/u-s-c-arms-market-104005

List of the Companies Profiled in the Report:

• Siemens Healthcare GmbH (Germany)


• Koninklijke Philips N.V. (Netherlands)


• GE HealthCare (U.S.)


• Shimadzu Corporation (Japan)


• Hologic Inc. (U.S.)


• Ziehm Imaging GmbH (Germany)


• CANON MEDICAL SYSTEMS CORPORATION (Japan)


• Fujifilm Holdings Corporation (Japan)

Further Report Findings

• The cardiology segment held a dominant position in the market in 2022 as the incidence of cardiovascular diseases is on the rise in the U.S. This has also increased the number of cardiac surgeries in the country, thereby boosting the adoption of c-arms.


• The Flat Panel Detector (FPD) segment dominated the market in 2022 as these detectors offer various advantages. They include compact structure and creating high-resolution images. Moreover, the growing launch of technologically advanced FPDs is also projected to accelerate the segment’s growth.


• Mobile c-arms segment captured a dominant share of the U.S. market in 2022 as these devices are finding increased usage due to their many advantages. One of the most prominent benefits of these devices is their easy positioning and movement, which enables the patient to move around, to produce high-quality images.

Table of Segmentation